BRIEF-BioXcel Therapeutics Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing

Reuters
Oct 30
BRIEF-BioXcel <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Inc - Updates On sNDA Submission For IGALMI Label Expansion - SEC Filing

Oct 30 (Reuters) - BioXcel Therapeutics Inc BTAI.O:

  • BIOXCEL THERAPEUTICS INC - UPDATES ON SNDA SUBMISSION FOR IGALMI LABEL EXPANSION - SEC FILING

  • BIOXCEL THERAPEUTICS INC - EXPECTS SNDA SUBMISSION COMPLETION EARLY Q1 2026 - SEC FILING

Source text: [ID:n0001104659-25-104009]

Further company coverage: BTAI.O

(Reporting by Anhata Rooprai)

((Anhata.Rooprai@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10